Media Partnership Between Biomedicines and the Barcelona Blood–Brain Barrier Conference 2026, 3–5 November 2026, Barcelona, Spain

Biomedicines (ISSN: 2227-9059, IF 3.9) is proud to announce its role as a media partner for the Barcelona Blood–Brain Barrier Conference 2026. This sponsorship highlights the journal’s commitment to supporting the scholarly community and engaging in critical industry discussions with the public.

Date: 3–5 November 2026
Location: Barcelona, Spain
Website: https://premc.org/blood-brain-barrier-conference/

The Barcelona Blood–Brain Barrier Conference 2026 will bring together scientists from across the globe to discuss emerging topics in BBB physiology, pathology and translational research. This interdisciplinary event will incorporate neuroscience, vascular biology, protein engineering, bioengineering, and nanomedicine to provide a unique platform to foster collaboration and address challenges shaping the future of this field.
About the Media Partner: Biomedicines

Biomedicines is an open access journal devoted to all aspects of research on human health and disease, the discovery and characterization of new therapeutic targets, therapeutic strategies, research of naturally driven biomedicines, pharmaceuticals, and biopharmaceutical products. As the media partner of the Barcelona Blood–Brain Barrier Conference 2026, Biomedicines will feature the conference highlights, research spotlights, and author opportunities for attendees and the blood–brain barrier research community within the broader field of biomedicines.

We look forward to seeing you at the Barcelona Blood–Brain Barrier Conference 2026.